RGS 0.00% 12.0¢ regeneus ltd

Regeneus is launching its first HiQCell offshore treatment...

  1. Regeneus is launching its first HiQCell offshore treatment centre in Singapore, which is a major milestone for the company. The Clinic will be led by Dr Patrick Goh, a leading sports and exercise medicine specialist, with first treatments expected to commence in late 2014.

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.